Skip to main content
Premium Trial:

Request an Annual Quote

Australia Approves Life Tech Real-Time PCR Workflow for Pathogen Detection in Meat Exports

NEW YORK (GenomeWeb News) – Australia's Department of Agriculture has approved Life Technologies' MicroSEQ Real-Time PCR workflow to detect pathogens in Australian meat and meat products for export, the company said today.

The agency approved workflows for detecting E. coli O157:H7 in raw ground beef and beef trim, Salmonella, and Listeria monocytogenes in meat and meat products. The workflows approved include the use of the PrepSEQ Rapid Spin Sample Preparation Kit or Automated PrepSEQ Nucleic Acid Extraction Kit, MicroSEQ Detection Kits, and 7500 Fast Real-Time PCR instrument, guided by the RapidFinder Express Software for data gathering, Life Tech said.

According to the company, Australia is the world's second-largest beef exporter. Because many food products are subject to testing and many countries require testing methods "under their country's regulation including methods that are prior to the approval by the government of Australia," microbiological testing is crucial to the export process, it said.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.